Skip to content
OpenCapital
Get started

Avanos Medical AVNS Revenue

Revenue at other companies

DJT
Trump Media & Technology GroupDJT
$871.2K+6.1%
ADMA Biologics logo
ADMA BiologicsADMA
$114.49M-0.3%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$666.95M-53.0%
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
$658.93M+14.2%
Photronics logo
PhotronicsPLAB
$209.94M-0.5%
First BanCorp logo
First BanCorpFBP
$258.64M+4.2%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's revenue?
Avanos Medical (AVNS) reported revenue of $182.2M in Q1 2026.
How has Avanos Medical's revenue changed year-over-year?
Avanos Medical's revenue increased by 8.8% year-over-year, from $167.5M to $182.2M.
What is the long-term trend for Avanos Medical's revenue?
Over 4 years (2021 to 2025), Avanos Medical's revenue has grown at a 4.5% compound annual growth rate (CAGR), from $587M to $701.2M.
What does revenue mean?
Represents the total consideration received or receivable from customers for the sale of goods or services in the ordinary course of business, excluding any sales-related taxes. This metric serves as the primary indicator of top-line growth and market demand for the company's medical device portfolio.